(Q51586434)

7 April 2018

title

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. (English)

1 reference

7 April 2018

1 reference

1 reference

Matthias Maruschke

1

1 reference

7 April 2018

D Reuter

2

1 reference

7 April 2018

D Koczan

3

1 reference

7 April 2018

O W Hakenberg

4

1 reference

7 April 2018

H-J Thiesen

5

1 reference

7 April 2018

publication date

16 March 2011

1 reference

7 April 2018

published in

BJU International

1 reference

7 April 2018

volume

108

1 reference

7 April 2018

issue

2 Pt 2

1 reference

7 April 2018

page(s)

E29-35

1 reference

7 April 2018

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Validation of computational methods in genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

The molecular classification of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Gene expression profiling reveals the profound upregulation of hypoxia-responsive genes in primary human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Oxygen sensing by HIF hydroxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Cellular oxygen sensing need in CNS function: physiological and pathological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Inhibitor of apoptosis protein survivin regulates vascular injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Gene-set approach for expression pattern analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

PAGE: parametric analysis of gene set enrichment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

The high-level similarity of some disparate gene expression measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

Noise filtering and nonparametric analysis of microarray data underscores discriminating markers of oral, prostate, lung, ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09794.X

10.1111/J.1464-410X.2010.09794.X

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018